AU1578795A - Enantiomerically pure (+)-liarozole - Google Patents

Enantiomerically pure (+)-liarozole

Info

Publication number
AU1578795A
AU1578795A AU15787/95A AU1578795A AU1578795A AU 1578795 A AU1578795 A AU 1578795A AU 15787/95 A AU15787/95 A AU 15787/95A AU 1578795 A AU1578795 A AU 1578795A AU 1578795 A AU1578795 A AU 1578795A
Authority
AU
Australia
Prior art keywords
liarozole
enantiomerically pure
enantiomerically
pure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU15787/95A
Other versions
AU689206B2 (en
Inventor
Marc Gaston Venet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of AU1578795A publication Critical patent/AU1578795A/en
Application granted granted Critical
Publication of AU689206B2 publication Critical patent/AU689206B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU15787/95A 1994-02-18 1995-02-10 Enantiomerically pure (+)-liarozole Expired - Fee Related AU689206B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94200420 1994-02-18
EP94200420 1994-02-18
PCT/EP1995/000490 WO1995022540A1 (en) 1994-02-18 1995-02-10 Enantiomerically pure (+)-liarozole

Publications (2)

Publication Number Publication Date
AU1578795A true AU1578795A (en) 1995-09-04
AU689206B2 AU689206B2 (en) 1998-03-26

Family

ID=8216652

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15787/95A Expired - Fee Related AU689206B2 (en) 1994-02-18 1995-02-10 Enantiomerically pure (+)-liarozole

Country Status (12)

Country Link
EP (1) EP0745077A1 (en)
JP (1) JPH09508914A (en)
CN (1) CN1141042A (en)
AU (1) AU689206B2 (en)
CA (1) CA2182583A1 (en)
IL (1) IL112688A0 (en)
MX (1) MX9603316A (en)
NZ (1) NZ279227A (en)
SG (1) SG52325A1 (en)
TW (1) TW401415B (en)
WO (1) WO1995022540A1 (en)
ZA (1) ZA951343B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996019991A1 (en) * 1994-12-28 1996-07-04 Janssen Pharmaceutica N.V. Benzimidazoles as inhibitors of calcitriol metabolism
EP1992228A1 (en) * 2007-05-14 2008-11-19 Bayer CropScience AG Insecticidal substituted thiourea derivatives
US9138393B2 (en) * 2013-02-08 2015-09-22 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin
US9144538B2 (en) * 2013-02-08 2015-09-29 The Procter & Gamble Company Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders

Also Published As

Publication number Publication date
WO1995022540A1 (en) 1995-08-24
JPH09508914A (en) 1997-09-09
TW401415B (en) 2000-08-11
CN1141042A (en) 1997-01-22
CA2182583A1 (en) 1995-08-24
MX9603316A (en) 1997-02-28
EP0745077A1 (en) 1996-12-04
NZ279227A (en) 1997-11-24
IL112688A0 (en) 1995-05-26
ZA951343B (en) 1996-08-19
AU689206B2 (en) 1998-03-26
SG52325A1 (en) 1998-09-28

Similar Documents

Publication Publication Date Title
AU3304795A (en) Bisresorcinyltriazines
AU2832295A (en) Cytoanalyzer
AU2837895A (en) Thiazine- or thiazepine-derivatives
AU4131596A (en) Polyglycomers
AU4044795A (en) Handleset
AU2308295A (en) Heterocyclylbenzonitriles
AU1963395A (en) Boom-structure
AU4029295A (en) Thienopyridones
AU7469594A (en) Poop-scoop
AU3166195A (en) Acylimidazopyridines
AU1578795A (en) Enantiomerically pure (+)-liarozole
AU4590996A (en) Boekomslag
AUPM365494A0 (en) Pre-chiller
AU3166095A (en) Benzylimidazopyridines
AU1578895A (en) Enantiomerically pure(-)-liarozole
AU2411395A (en) Hydrocopter
AU3446995A (en) Biodestumping
AU1603595A (en) Meso-azanoradamantanes
AU3417395A (en) Hydro-ethano-indeno-pyridines
AUPM374794A0 (en) Compartmentalizer
AU2003200421A1 (en) Enantiomerically pure beta-D-dioxolane-nucleosides
AU658811B3 (en) Bum-bag
AU693176C (en) Campervan
AU661263B3 (en) Rotakite
AUPM675594A0 (en) Headgear

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application